Cardiovascular effects of sevoflurane

Citation
N. Rolf et H. Van Aken, Cardiovascular effects of sevoflurane, ANAESTHESIS, 47, 1998, pp. S11-S18
Citations number
45
Categorie Soggetti
Aneshtesia & Intensive Care
Journal title
ANAESTHESIST
ISSN journal
00032417 → ACNP
Volume
47
Year of publication
1998
Supplement
1
Pages
S11 - S18
Database
ISI
SICI code
0003-2417(199811)47:<S11:CEOS>2.0.ZU;2-F
Abstract
The cardiovascular effects of sevoflurane are similar to those of isofluran e with some minor exceptions. In contrast to isoflurane and particularly to desflurane, sevoflurane has not been associated with increases in heart ra te in healthy volunteers and in patients. The coronary vasodilatory potency of sevoflurane appears to be lower than that of isoflurane and it has not been associated with a reduction of blood flow to collateral myocardium in dogs with steal-prone anatomy. In several multi-center studies of patients with coronary artery disease or at high risk for coronary artery disease re ceiving either sevoflurane or isoflurane far either cardiac or non-cardiac surgery, the incidence of myocardial ischemia and infarction did not differ between treatment groups. In both human and animal models,sevoflurane pres erves cerebral blood flow and reduces cerebral metabolic rate, much like is oflurane.